<DOC>
	<DOC>NCT01227083</DOC>
	<brief_summary>Comparison of the responsiveness of two different asthma-specific QOL measures (AQLQ and cAQOL) in Korean patients with persistent asthma</brief_summary>
	<brief_title>2nd_Computerized Asthma Specific Quality of Life(cAQOL)</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>Patient aged 2070 years Patient diagnosed with asthma over six months ago Asthma diagnosis Airway reversibility, FEV1 ≥ 12% and 200mL or Airway hyperresponsiveness, PC20 &lt; 16 mg/mL or More than two weeks, more than 2 times a day in excess of 20% PEFR diurnal variability patient FEV1 55100% of predicted value patient Inhaled corticosteroids alone or inhaled corticosteroids and beta agonists used patient Currently, at least if you have one or more asthma symptoms, asthma control test (ACT • Asthma Control Test) score of less than 19 characters Patients who sufficiently listen to the purpose and content of this trial and the properties of investigational products and voluntarily agree with the participation to sign a written consent approved by IRB of Ajou University Medical Center before the participation in this trial Current smoking or smoking in the past 15packyears Patients who show a symptom of an acute disease within 14 days before the beginning of this trial (administration of trial medication) Recent changes in asthma treatment for 28days Chronic diseases that affect the quality of life</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>AQLQ and cAQOL</keyword>
</DOC>